ReferIndia News MedPlus Subsidiary Drug License Suspensions Rise to 12 Stores

ReferIndia News

Mumbai’s Trusted Investment Experts

24+ years of financial planning, portfolio management & wealth growth.

Learn More
News Image

MedPlus Subsidiary Drug License Suspensions Rise to 12 Stores

Published on: May 23, 2026, 7:24 p.m. | Source: scanx.trade

MedPlus Health Services disclosed that its subsidiary, Optival Health Solutions, received two additional drug license suspension orders for stores in Karnataka, dated May 22 and May 23, 2026. This brings the total number of affected stores to twelve across Maharashtra, Telangana, Karnataka, and Delhi, with all suspensions occurring under Rule 65 of the Drugs and Cosmetics Act, 1940. The potential revenue loss from the two new stores is Rs 0.54 lacs and Rs 1.98 lacs, respectively, increasing the total potential revenue impact to Rs 14.80 lacs.

Checkout more news
Ad Banner

Grow. Protect. Prosper.

Your wealth deserves expert care. Our advisors craft personalized investment plans designed to grow and safeguard your assets.

Schedule Call
ReferIndia News contact